Oyama T, Vickery A L, Preffer F I, Colvin R B
Second Department of Pathology, Gunma University School of Medicine, Japan.
Hum Pathol. 1994 Mar;25(3):271-5. doi: 10.1016/0046-8177(94)90199-6.
As a possible diagnostic aid in the often difficult histopathologic distinction of thyroid follicular carcinomas from adenomas based on invasion most flow cytometry studies have indicated a higher aneuploidy incidence in carcinomas. However, these reports often are difficult to analyze mainly due to nonuniformity of pathologic diagnostic criteria. The present study compares the flow cytometry results of 65 follicular tumors with pathologic findings based on the World Health Organization's specific diagnostic and staging criteria. Aneuploidy was significantly higher in the 28 cancers than in the 27 hypercellular (fetal and embryonal) adenomas (57% v 22%; P = .02). There was a high percentage of aneuploidy (75%; nine of 12 cases) in the widely invasive follicular carcinomas, compared with 40% (six of 15 cases) in the minimally invasive carcinomas, 22% (six of 27 cases) in the hypercellular adenomas, and 10% (one of 10 cases) in the normofollicular or macrofollicular adenomas. However, aneuploidy was not significantly different between the most difficult differential histopathologic diagnoses of minimally invasive follicular carcinoma (40%; six of 15 cases) and hypercellular adenoma (22%; six of 27 cases) (P = .12). Other data included relatively high frequencies of aneuploidy in hypercellular adenomas (29%; six of 21 cases) and diploid status of carcinomas (36%; 12 of 33 cases). In summary, although the overall findings show a trend toward increasing aneuploidy from well-differentiated and hypercellular adenomas to minimally and widely invasive follicular carcinomas, the aneuploidy data are inconsistent and indicative of its nonspecificity and limited diagnostic usefulness.
基于侵袭情况,甲状腺滤泡癌与腺瘤在组织病理学上的区分往往存在困难,而流式细胞术研究表明,作为一种可能的诊断辅助手段,癌中的非整倍体发生率较高。然而,这些报告往往难以分析,主要原因是病理诊断标准不统一。本研究根据世界卫生组织的特定诊断和分期标准,将65例滤泡性肿瘤的流式细胞术结果与病理结果进行了比较。28例癌中的非整倍体发生率显著高于27例高细胞(胎儿型和胚胎型)腺瘤(57%对22%;P = 0.02)。广泛侵袭性滤泡癌中的非整倍体发生率较高(75%;12例中的9例),相比之下,微侵袭性癌为40%(15例中的6例),高细胞腺瘤为22%(27例中的6例),正常滤泡或大滤泡腺瘤为10%(10例中的1例)。然而,微侵袭性滤泡癌(40%;15例中的6例)和高细胞腺瘤(22%;27例中的6例)这两种最难鉴别的组织病理学诊断之间,非整倍体发生率并无显著差异(P = 0.12)。其他数据包括高细胞腺瘤中非整倍体的相对高频率(29%;21例中的6例)以及癌中的二倍体状态(36%;33例中的12例)。总之,尽管总体结果显示从高分化和高细胞腺瘤到微侵袭性和广泛侵袭性滤泡癌,非整倍体有增加的趋势,但非整倍体数据并不一致,表明其缺乏特异性且诊断价值有限。